Treatment-Resistant Bipolar Depression: A STEP-BD Equipoise Randomized Effectiveness Trial of Antidepressant Augmentation With Lamotrigine, Inositol, or Risperidone
Andrew A. Nierenberg(Andrews University), Mark S. Bauer(University of Pennsylvania), Terence A. Ketter(Stanford University), Lauren B. Marangell(Baylor College of Medicine), Sachiko Miyahara, Stephen R. Wisniewski(University of Iowa), Michael J. Ostacher(VA Palo Alto Health Care System), David J. Miklowitz(University of California, Los Angeles), Joseph R. Calabrese(Case Western Reserve University), Michael E. Thase(Unknown)
Cited by 255
Related Papers
Effectiveness-implementation Hybrid Designs
|Medical Care|2012|4.2k
An introduction to implementation science for the non-specialist
|BMC Psychology|2015|2k
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder
|Nature Genetics|2008|1.3k
Implementation science: What is it and why should I care?
|Psychiatry Research|2019|1.2k